Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

"For too long, the Parkinson's community has had limited treatment options for advanced disease," Dr. Robert A. Hauser, ...

The progression of Parkinson's disease often requires a change of therapy. An expert explains when this should be done and ...

we could identify individuals with specific deficiencies and administer oral riboflavin and biotin supplements to those with ...

including thrashing and other sudden movements Change in blood pressure Parkinson's disease has no cure, but there are treatment options to control your symptoms and improve your quality of life ...

A radical Parkinson's treatment that delivers a drug directly to the brain has been tested in people. Patients in the trial were either given the drug, which is administered via a "port" in the ...

“There are a total of 93 products in Phase I-III development within the 7MM for the treatment of Parkinson’s,” Palmer said. “66% of these are prospective neuroprotective agents or DMT ...

People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital twin’ brain, thanks to a £1m funding ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

a-syn is believed to be a key protein in the disease due to its high prevalence in patients with Parkinson's disease. Treatment with ACI-7104.056 induced an increase in anti-a-syn antibodies on ...

Thus, another clinical candidate in its pipeline would be Risvodetinib [IKT-148009] for the treatment of patients with Parkinson's Disease [PD]. The use of this kinase inhibitor is being explored ...